Ces Urol 2004, 8(3):46-48 | DOI: 10.48095/cccu2004021

The influence of stenting on the disintegration of in vitro ureterolithiasis

A. Petřík1, F. Záťura2, J. Beneš3
1 urologické oddělení Nemocnice České Budějovice a.s.
2 Urologická klinika Univerzity Palackého, Olomouc
3 Ústav biofyziky a informatiky 1. LF UK, Praha

The concrement disintegration in the ureter at ESWL is influenced by the type and the characteristic of the device used (especially by the type of the impacting wave and the type of the concrement localization), by the total energy applied during the therapy and the frequency of the impacting waves. However, the concrement composition and the presence of the stent are also of a great influence. To evaluate the influence of the stent on the effectiveness of extracorporal lithotripsy in the ureter there an in vitro experiment has been designed. In the group without the stent the relative weight loss of the standard model of artificial concrement was 72,465 %, in the group with the stent it was 63,674 % (p < 0,05). The experiment performed proves the negative influence of the introduced stent on the concrement disintegration in the ureter.

Keywords: ESWL, ureteral, stone fragmentation, JJ-stent

Published: June 1, 2004 


References

  1. Chaussy C, Fuchs G. Current State and Future Developments of Non-invasive Treatment of Human Urinary Stones with Extracorporeal Shock Wave Lithotripsy. J Urol 1989; 141: 782-789. Go to original source... Go to PubMed...
  2. Lingeman JE, Shirreell WL, Newman DM.Management of upper ureteral calculi with extracorporeal shock wave lithotripsy. J Urol 1987; 138: 720. Go to original source... Go to PubMed...
  3. Harada M, Inaba Y, Okamoto M. Treatment of ureteral stones by extracorporeal shock wave lithotripsy: with ureteral catheter or in situ? J Endourol 1994; 8: 9-11. Go to original source... Go to PubMed...
  4. Segura JW, Preminger GM, Assimos DG et al. Ureteral Stones Clinical Guidelines. Panel Summary Report on the Management of Ureteral Calculi. J Urol 1997; 158: 1915-21. Go to original source... Go to PubMed...
  5. Ryan PC, Lennon GM, McLean PA, Fitzpatrick JM. The effects of acute and chronic JJ stent placement on upper urinary tract motility and calculus transit. Br J Urol 1994; 74: 434-9. Go to original source... Go to PubMed...
  6. Robert M, Delbos O, Guiter J, Grasset D. In situ piezoelectric extracorporeal shock wave lithotripsy of ureteric stones. Br J Urol 1995; 76: 435-9. Go to original source... Go to PubMed...
  7. Kim HH, Lee JH, Park MS, Lee SE, Kim SW. In situ extracorporeal shockwave lithotripsy for ureteral calculi: investigation of factors influencing stone fragmentation and appropriate number of sessions for changing treatment modality. J Endourol 1996; 10: 501-5. Go to original source... Go to PubMed...
  8. Eisenmenger W. The Mechanism of Stone Fragmentation in ESWL. Ultrasound Med Biol; 2001 27: 583-693. Go to original source...
  9. Thompson AC, Shamsuddin AB, Mishriki SF, Crocker P, Ramsay JWA. In situ ESWL for Ureteric Stones: the Adverse Effect of JJ Stenting. Br J Urol 1996; 77 (Suppl 1): 5.
  10. Tailly GG. In situ SWL of ureteral stones: comparison between an electrohydraulic and an electromagnetic shockwave source. J Endourol 2002; 16: 209-14. Go to original source... Go to PubMed...
  11. Zhou Y, Cocks FH, Preminger GM, Zhong P. The effect of treatment strategy on stone comminution efficiency in shock wave lithotripsy. J Urol 2004; 172: 349-54. Go to original source... Go to PubMed...
  12. Paterson RF, Lifshitz DA, Lingeman JE, Evan AP, Connors BA, Fineberg NS, Williams JC, McAteer JA. Stone fragmentation during shock wave lithotripsy is improved by slowing the shock wave rate: studies with a new animal model. J Urol 2002; 168: 2211-5. Go to original source... Go to PubMed...
  13. Williams JC, Saw KC, Paterson RF, Hatt EK, McAteer JA, Lingeman JE. Variability of renal stone fragility in shock wave lithotripsy. Urology 2003; 61: 1092-6. Go to original source... Go to PubMed...





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit